Study of Farnesyl Protein Transferase Inhibitor (FPTI) in Patients With Leukemia (Study P00701)

NCT00034684 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

132

Enrollment

INDUSTRY

Sponsor class

Conditions

Leukemia
Myelodysplastic Syndromes
Leukemia, Myeloid, Chronic
Blast Crisis
Leukemia, Lymphocytic

Interventions

DRUG: Farnesyl Protein Transferase Inhibitor

Sponsor

Merck Sharp & Dohme LLC